This IQVIA blog post details how Patient Support Programs (PSP) have evolved from providing drug bridging and financial support to a more comprehensive portfolio of services including, but not limited to: providing infusions, injection support, life coaching, and access to allied health professionals.
The role of PSPs has become increasingly important in enhancing the care of patients as they begin their treatment journey. At the same time, there has been a growing need for manufacturers to generate real world evidence (RWE). Stakeholders, including payers, healthcare practitioners (HCPs) and even patients, want to understand the real-world effectiveness and safety of therapies, in order to more clearly define a drug’s value. Read more here.
(Source: Calum Neish, Director, Business Development, RWS)